Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02.
Curran WJ Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, et al. Curran WJ Jr, et al. Among authors: phillips tl. J Clin Oncol. 1993 May;11(5):857-62. doi: 10.1200/JCO.1993.11.5.857. J Clin Oncol. 1993. PMID: 8487050 Clinical Trial.
A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02.
Curran WJ Jr, Scott CB, Nelson JS, Weinstein AS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, Powlis WD, et al. Curran WJ Jr, et al. Among authors: phillips tl. Cancer. 1992 Dec 15;70(12):2909-17. doi: 10.1002/1097-0142(19921215)70:12<2909::aid-cncr2820701230>3.0.co;2-6. Cancer. 1992. PMID: 1451073 Clinical Trial.
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD, Scott CB, Rotman M, Rubin P, Murray K, Sause W, Asbell S, Comis R, Curran W, Nelson J, Davis RL, Levin VA, Lamborn K, Phillips TL. Prados MD, et al. Among authors: phillips tl. Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):653-9. doi: 10.1016/s0360-3016(97)00770-0. Int J Radiat Oncol Biol Phys. 1998. PMID: 9486616
Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group protocol 83-11.
Curran WJ Jr, Cox JD, Azarnia N, Byhardt RW, Shin KH, Emani B, Phillips TL, Selim H, Herskovic A, Mohiuddin M, et al. Curran WJ Jr, et al. Among authors: phillips tl. Cancer. 1991 Aug 1;68(3):509-16. doi: 10.1002/1097-0142(19910801)68:3<509::aid-cncr2820680311>3.0.co;2-7. Cancer. 1991. PMID: 1648432 Clinical Trial.
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr. Prados MD, et al. Among authors: phillips t. Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1109-15. doi: 10.1016/s0360-3016(99)00265-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10613302 Clinical Trial.
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr. Prados MD, et al. Among authors: phillips t. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1147-52. doi: 10.1016/j.ijrobp.2003.08.024. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001257 Clinical Trial.
Initial pharmacology and toxicology of intravenous desmethylmisonidazole.
Coleman CN, Wasserman TH, Phillips TL, Strong JM, Urtasun RC, Schwade JG, Johnson RJ, Zagars G. Coleman CN, et al. Among authors: phillips tl. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):371-5. doi: 10.1016/0360-3016(82)90642-3. Int J Radiat Oncol Biol Phys. 1982. PMID: 7107354
Radiation tolerance of the spinal cord.
Wara WM, Phillips TL, Sheline GE, Schwade JG. Wara WM, et al. Among authors: phillips tl. Cancer. 1975 Jun;35(6):1558-62. doi: 10.1002/1097-0142(197506)35:6<1558::aid-cncr2820350613>3.0.co;2-7. Cancer. 1975. PMID: 1148990
329 results